| Original language | English |
|---|---|
| Pages (from-to) | 2406-2407 |
| Number of pages | 2 |
| Journal | Journal of the American College of Cardiology |
| Volume | 72 |
| Issue number | 19 |
| DOIs | |
| Publication status | Published or Issued - 6 Nov 2018 |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Nightly Variation in Sleep Apnea Severity as Atrial Fibrillation Risk. / Linz, Dominik; Brooks, Anthony G.; Elliott, Adrian D. et al.
In: Journal of the American College of Cardiology, Vol. 72, No. 19, 06.11.2018, p. 2406-2407.Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Nightly Variation in Sleep Apnea Severity as Atrial Fibrillation Risk
AU - Linz, Dominik
AU - Brooks, Anthony G.
AU - Elliott, Adrian D.
AU - Kalman, Jonathan M.
AU - McEvoy, R. Doug
AU - Lau, Dennis H.
AU - Sanders, Prash
N1 - Funding Information: Please note: LivaNova R&D department exported the deidentified pacemaker records. Dr. Linz is supported by a Beacon Research Fellowship by the University of Adelaide; has served on the advisory board of LivaNova and Medtronic; has received lecture and/or consulting fees from LivaNova, Medtronic, and ResMed; and has received research funding from Sanofi, ResMed, and Medtronic. Dr. Brooks is an employee of Microport. Dr. Elliott is supported by an Early Career Fellowship from the National Heart Foundation of Australia. Drs. Kalman, McEvoy, and Sanders are supported by Practitioner Fellowships from the National Health and Medical Research Council of Australia. Dr. McEvoy has received research funding from Philips Respironics, ResMed, and Fisher & Paykel. Dr. Lau is supported by the Robert J. Craig Lectureship from the University of Adelaide; has received consulting fees from St. Jude Medical; and has received speaker's fees from St. Jude Medical, Bayer, Boehringer Ingelheim, and Bristol-Myers Squibb/Pfizer. Dr. Sanders is supported by the National Heart Foundation of Australia; has served on the advisory board of Biosense Webster, Medtronic, St. Jude Medical, Boston Scientific, and CathRx; has received lecture and/or consulting fees from Biosense Webster, Medtronic, St. Jude Medical, and Boston Scientific; has received research funding from Medtronic, St. Jude Medical, Boston Scientific, Biotronik, and Sorin; and the University of Adelaide has received, on his behalf, lecture and/or consulting fees from Biosense Webster, Medtronic, St. Jude Medical, and Boston Scientific, and research funding from Medtronic, St. Jude Medical, Boston Scientific, Biotronik, and LivaNova.
PY - 2018/11/6
Y1 - 2018/11/6
UR - http://www.scopus.com/inward/record.url?scp=85055181391&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2018.08.2159
DO - 10.1016/j.jacc.2018.08.2159
M3 - Letter
C2 - 30384896
AN - SCOPUS:85055181391
VL - 72
SP - 2406
EP - 2407
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
SN - 0735-1097
IS - 19
ER -